Search by Drug Name or NDC
NDC 00006-4943-00 PNEUMOVAX 23 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL Details
PNEUMOVAX 23 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
PNEUMOVAX 23 is a INTRAMUSCULAR; SUBCUTANEOUS INJECTION, SOLUTION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARID.
Product Information
| NDC | 00006-4943 |
|---|---|
| Product ID | 0006-4943_327ad052-4941-44c2-9511-352a39e7834a |
| Associated GPIs | 17200065002205 |
| GCN Sequence Number | 048548 |
| GCN Sequence Number Description | pneumococcal 23-val p-sac vac VIAL 25MCG/0.5 INJECTION |
| HIC3 | W7L |
| HIC3 Description | GRAM POSITIVE COCCI VACCINES |
| GCN | 14287 |
| HICL Sequence Number | 004212 |
| HICL Sequence Number Description | PNEUMOCOCCAL 23-VALENT POLYSACCHARIDE VACCINE |
| Brand/Generic | Brand |
| Proprietary Name | PNEUMOVAX 23 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | pneumococcal vaccine polyvalent |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; SUBCUTANEOUS |
| Active Ingredient Strength | 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25 |
| Active Ingredient Units | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| Substance Name | STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 10A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 11A CAPSULAR POLYSACCHARIDE ANTIGEN; STREPTOCOCCUS PNEUMONIAE TYPE 12F CAPSULAR POLYSACCHARID |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immuni |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA101094 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-4943-00 (00006494300)
| NDC Package Code | 0006-4943-00 |
|---|---|
| Billing NDC | 00006494300 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4943-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4943-01) |
| Marketing Start Date | 1983-07-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |